• Eliminating Pollen Interference in EEM Fluorescence Detectio

  2026-05-26

  Zhang et al. introduce a robust workflow to identify and remove pollen-induced spectral interference in excitation–emission matrix (EEM) fluorescence spectroscopy, markedly improving hazardous bioaerosol classification. Their approach enhances detection accuracy for hazardous substances, including toxins and bacteria, with direct implications for rapid public health monitoring.

• Practical Guide: Cell Counting Kit-8 (CCK-8) Plus for Cell A

  2026-05-26

  The Cell Counting Kit-8 (CCK-8) Plus enables rapid, quantitative measurement of cell viability, proliferation, and cytotoxicity using a sensitive, water-soluble tetrazolium salt assay. It is well-suited for high-throughput screening and precise cell-based assays across diverse cell types, but should not be used where metabolic activity does not correlate with cell number or in non-enzymatic viability contexts.

• ABT-263 (Navitoclax): Precision Apoptosis Tools for Cancer R

  2026-05-25

  ABT-263 (Navitoclax) is redefining apoptosis research by enabling highly selective and quantifiable cell death assays in cancer biology. Its nanomolar Bcl-2 family inhibition and robust performance in pediatric leukemia models make it the preferred tool for dissecting mitochondrial apoptosis, troubleshooting resistance, and accelerating translational workflows.

• Protease Inhibitor Cocktail EDTA-Free: Advanced Bench Workfl

  2026-05-25

  APExBIO’s Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) redefines reliable protein extraction for phosphorylation-sensitive and post-translational modification workflows. Its EDTA-free, broad-spectrum formulation uniquely preserves protein integrity in even the most challenging biological samples.

• Mechanistic Leverage: Next-Gen mRNA Reporters in Translation

  2026-05-24

  This thought-leadership article examines how the design of EZ Cap™ EGFP mRNA (5-moUTP) advances translational research by uniting mechanistic innovation and workflow reproducibility. We explore recent breakthroughs in mRNA delivery and immune evasion, connect cutting-edge mechanistic insights to laboratory protocols, and provide strategic guidance for researchers seeking robust, quantifiable gene expression in complex biological systems.

• Golgi-Tracker Green: Photostable Live-Cell Golgi Imaging Sol

  2026-05-23

  Golgi-Tracker Green empowers researchers with highly specific, photostable live-cell Golgi apparatus labeling, outperforming conventional probes in clarity and reproducibility. Its BODIPY FL-labeled C5-ceramide foundation enables robust workflows for lipid transport and sphingolipid metabolism analysis.

• Omeprazole: Technical Guide for H+,K+-ATPase Inhibition

  2026-05-22

  Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor used in research to study gastric acid secretion and antiulcer mechanisms. This product is best suited for controlled laboratory assays modeling peptic ulcer disease and related gastric acid disorders, but should not be used for diagnostic or medical applications. Researchers must account for its solubility, storage stability, and workflow integration to ensure reproducible results.

• Enhancing Kidney-Targeted mRNA Nanoparticle Loading via Exci

  2026-05-22

  This study explores how excipients modulate the mRNA loading capacity of polymeric mesoscale nanoparticles for kidney-targeted delivery. The findings demonstrate that certain excipients improve mRNA encapsulation and stability while maintaining nanoparticle size, offering promising advances for renal gene therapy platforms.

• EZ Cap™ mCherry mRNA: Precision Red Fluorescent Protein Expr

  2026-05-21

  Discover how EZ Cap™ mCherry mRNA enables reliable red fluorescent protein expression with enhanced mRNA stability and minimal immune activation. This article bridges advanced assay needs with the latest biosensor and reporter gene innovations.

• Amyloid Beta-Peptide (1-40) (human): Applied Workflows & Inn

  2026-05-21

  Amyloid Beta-Peptide (1-40) (human) from APExBIO enables robust, reproducible modeling of amyloid aggregation and neurotoxicity, empowering translational Alzheimer's disease research. Discover advanced workflow enhancements, real-world troubleshooting, and actionable protocol tips grounded in cutting-edge studies.

• DOT1L Inhibition Primes Immunity, Enhances Lenalidomide Resp

  2026-05-20

  This study demonstrates that targeting DOT1L, an epigenetic methyltransferase, activates innate immune signaling and amplifies the anti-myeloma efficacy of lenalidomide. The findings suggest that combining DOT1L inhibition with immunomodulatory drugs could address resistance mechanisms and improve multiple myeloma outcomes.

• Magnetic Nano-Antibodies Enable In Vivo CAR-T-Mimicry for Tu

  2026-05-20

  This study reports the development of a magnetic bispecific nano-antibody platform (M-BiNanoAb) for in vivo generation and guidance of CAR-T-mimicking cells, overcoming major barriers in solid tumor immunotherapy. The results highlight a new strategy to reprogram circulating T cells and precisely direct their migration into tumors, offering a promising alternative to traditional ex vivo CAR-T cell engineering.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dual-Reporter mRNA Assays

  2026-05-19

  Unlock dual fluorescence for real-time mRNA delivery and translation efficiency assays in advanced gene therapy research. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) from APExBIO streamlines quantitative workflows, minimizes innate immune activation, and enables robust functional validation in next-generation nanoparticle optimization.

• Lipid Nanoparticle Delivery of ABE8e Corrects COL7A1 in DEB

  2026-05-19

  This study demonstrates the efficient delivery of adenine base editor ABE8e using lipid nanoparticles (LNPs) to correct pathogenic COL7A1 mutations in dystrophic epidermolysis bullosa (DEB) fibroblasts in vitro. These findings highlight a promising gene editing strategy for inherited skin diseases and inform future workflows involving mRNA and protein tracking technologies.

• EZ Cap™ Cre mRNA (m1Ψ): High-Efficiency Gene Editing Workflo

  2026-05-18

  EZ Cap™ Cre mRNA (m1Ψ) delivers robust, low-immunogenicity Cre recombinase expression for gene editing and functional studies. Its Cap 1 and m1Ψ modifications support advanced mRNA delivery and streamline in vitro and in vivo protocols—backed by the reliability of APExBIO.

769 records 17/52 page Previous Next First page 上5页 1617181920 下5页 Last page